Correction to: Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement.


Journal

Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 24 6 2020
medline: 24 6 2020
entrez: 24 6 2020
Statut: ppublish

Résumé

The authors regret that the original published version of the above article contained errors. The authors requested that these be noted.

Identifiants

pubmed: 32572805
doi: 10.1007/s10067-020-05223-z
pii: 10.1007/s10067-020-05223-z
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

2495-2498

Commentaires et corrections

Type : ErratumFor

Références

Kitamura E, Kondo Y, Kanazawa N, Akutsu T, Nishiyama K, Iizuka T (2019) Autoimmune encephalitis as an extra-articular manifestation of rheumatoid arthritis. Intern Med 58:1007–1009
doi: 10.2169/internalmedicine.1846-18
Ichiose S, Oohashi N, Watabe R, Satou S, Hoshi K, YahikoZawa H, Watanabe M (2013) A 57-year-old female case of rheumatoid meningitis with mental symptoms for which anti-cyclic citrullinated peptides antibody in the cerebrospinal fluid was useful for diagnosis. Med J Nagano Red Cross Hosp 27:110–111. (conference proceedings)
Shibahara T, Matsushita T, Matsuo R, Fukushima Y, Fukuda K, Sugimori H, Kamouchi M, Kitazono T, Ago T (2016) Anti-cyclic citrullinated peptide antibody positive meningoencephalitis in the preclinical period of rheumatoid arthritis. Case Rep Neurol 8:156–160. https://doi.org/10.1159/000447627
doi: 10.1159/000447627
Lubomski M, Sy J, Buckland M, Lee AS, Richards B, Thompson E, Fulham M, Breen N, Morris K, Halmagyi GM (2019) Rheumatoid leptomeningitis presenting with an acute neuropsychiatric disorder. Pract Neurol 19:68–71. https://doi.org/10.1136/practneurol-2018-001978
doi: 10.1136/practneurol-2018-001978
Nissen MS, Nilsson AC, Forsberg J, Milthers J, Wirenfeldt M, Bonde C, Byg KE, Ellingsen T, Blaabjerg M (2019) Use of cerebrospinal fluid biomarkers in diagnosis and monitoring of rheumatoid meningitis. Front Neurol 10:666
doi: 10.3389/fneur.2019.00666
Asano K, Kamimura N, Tsuchihashi Y, Watanabe D, Takahashi R (2019) A 71-year-old female with rheumatoid meningitis who presented with characteristic imaging findings on brain MRI and was useful for diagnosis by anti-CCP antibody in cerebrospinal fluid. Rinsho Shinkeigaku (Clinical Neurology) 59:299. (conference proceedings)

Auteurs

Misako Higashida-Konishi (M)

Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo, 152-8902, Japan.

Keisuke Izumi (K)

Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo, 152-8902, Japan. izz@keio.jp.
Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. izz@keio.jp.

Masako Tsukamoto (M)

Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo, 152-8902, Japan.

Hiroaki Ohya (H)

Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo, 152-8902, Japan.

Nozomi Takasugi (N)

Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo, 152-8902, Japan.

Satoshi Hama (S)

Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo, 152-8902, Japan.

Yutaro Hayashi (Y)

Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo, 152-8902, Japan.

Mari Ushikubo (M)

Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo, 152-8902, Japan.

Kumiko Akiya (K)

Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo, 152-8902, Japan.

Araki Kazuhiro (A)

Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo, 152-8902, Japan.

Yutaka Okano (Y)

Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo, 152-8902, Japan.

Hisaji Oshima (H)

Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo, 152-8902, Japan.

Classifications MeSH